RESUMEN
Objective@#To observe the effect of calcium on biological characteristics (proliferation, apoptosis and cell cycle) of ALC ameloblasts. .@*Methods@#ALC cell lines were cultured in vitro in DMEM medium with high glucose at different concentrations (0, 2.0, 2.5, 3.0 and 3.5 mmol/L CaCl2 aqueous solution) for 24 h and 48 h, respectively. Changes of ALC cells under two kinds of incubation time were observed with an inverted microscope. CCK-8 method was used to analyze the effect of calcium ion on ALC cell proliferation. Hoechst staining was used to observe the effect of calcium ion on ALC cell apoptosis. PI staining and FCM method were used to analyze the effect of calcium ions on the growth cycle of ALC cells. Western blot was used to detect the effect of calcium ions on the expression of Cyclin A, Cyclin B and Cyclin D in ALC cells@*Results@#In the 0 mmol/L CaCl2 group, ALC cells were oval or polygonal in shape, and the cells were closely connected and grew like paving stones. In other concentration groups, the morphology of ALC cells did not change significantly after calcium intervention for 24 h and 48 h. Results of CCK-8 method showed that the survival rate of ALC cells slightly decreased with increasing calcium ions concentration after calcium intervention for 24 h and 48 h. However, there was no significant differences in this trend. Results of Hoechst staining showed that the number of ALC cell apoptosis did not increase significantly after different concentrations of calcium intervention for 24 h and 48 h. With the increase of calcium ion concentration, results of PI staining and FCM method showed that the cell cycle of ALC cells gradually increased in S phase and decreased in G1 and G2 phase gradually. Western blot results showed that the expression of Cyclin A and Cyclin B in ALC cells decreased and the expression of Cyclin D increased after different concentrations of calcium intervention for 24 h and 48 h. @*Conclusion@#In this study, calcium has no significant effect on the proliferation and apoptosis of ALC cells. Calcium, however, has an effect on the ALC cell cycle. Results of this study show that calcium ions has no obvious toxic or side effects on the ameloblasts, which could be used to explore the possible mechanism and effect of calcium on dental fluorosis.
RESUMEN
Objective: To investigate the expression of ALC1 protein during esophageal squamous cell carcinoma (ESCC) development and progression, so as to explore its association with clinicopathological characteristics and overall survival of ESCC patients, and the effect of ALC1 overexpression on malignant biological behavior of esophageal squamous cells. Methods: Immunohistochemistry (IHC) was used to detect ALC1 protein expression in 245 primary ESCC tissues and their paired normal esophageal mucous membranes, and to determine its correlation to gender, age, tumor cell differentiation, invasion, TNM stage, lymph nodes metastasis, and overall surviv-al rate of ESCC patients. MTT assay, colony formation assay, transwell invasion, and wound healing assay were used to observe the ef-fect of ALC1 on ESCC cell proliferation, invasion, and migration. Results: The expression ratio of ALC1 in esophageal squamous cell car-cinoma was higher compared with that in their paired normal esophageal mucous membranes (41.6% vs . 21.2% , P<0.05). Upregula-tion of ALC1 was associated with ESCC invasion, TNM stage, and lymph node metastasis (P<0.05). The overall survival of ESCC patients with ALC1 overexpression was significantly lower than that in patients with downregulated ALC1 expression (P=0.002). Therefore, ALC1 may promote the proliferation, invasion, and migration of ESCC cells. Conclusions: ALC1 upregulation may play an important role in the progression and development of ESCC. Upregulation of ALC1 leads to poorer disease prognosis, and could promote the prolifera-tion, invasion, and migration of the KYSE30 ESCC cells. Therefore, ALC1 may have potential prognostic value for ESCC patients.
RESUMEN
Objective To observe the effect of obstructive sleep apnea syndrome (OSAHS) patients with glycosylated hemoglobin (HbA1c) levels, assessment of continuous positive airway pressure (CPAP) effect on the level of HbA1c in patients with OSAHS. Methods From January 2013 to December 2016, eighty patients with OSAHS were divided into mild group, eighteen cases, moderate group twenty cases, severe group forty-two cases according to the apnea hypopnea index (AHI). Thirty healthy subjects were chosen as the control group. All the treatment groups were treated with CPAP for three months. Overnight polysomnography and HbA1c test were performed before and after treatment, and the control group was examined by HbA1c before treatment. Results The level of glycosylated hemoglobin in the middle and severe group was higher than that of the control group(P<0.05). After treatment, the glycated hemoglobin levels in the moderate and severe groups were significantly lower(P<0.05), and the sleep apnea hypopnea index, the lowest SaO2 and the average SaO2 level were significantly improved(P<0.01). Conclusion Glycated hemoglobin levels increased significantly in patients with moderate and severe OSAHS, and decreased HbA1c levels in patients with moderate and severe OSAHS after CPAP treatment.
RESUMEN
Kallistatin, which protects organs and cells against inflammation, fibrosis and oxidative stress, is mainly synthesized and secreted in liver. However, its relationship to human liver disease remains unclear. The purpose of this study was to explore the relationship between serum kallistatin and clinical evidence of both cirrhosis and hepatocellular carcinoma (HCC), and to determine if serum kallistatin levels could be used as a diagnostic indicator of hepatic health status, especially human liver cirrhosis (LC). Our cohort consisted of 115 patients with clinically proven liver fibrosis (LF), LC, or HCC by liver biopsies, and 31 healthy controls (CON). Serum kallistatin levels were quantified by ELISA. Results of the present study demonstrated that irrespective of the underlying etiology, serum kallistatin levels were significantly lower in the LF/LC group when compared with the CON group. A decrease in serum kallistatin levels appeared to reflect the extent of cirrhosis, with the lowest levels associated with higher grades of cirrhosis. Patients with LC had a noticeable correlation between serum kallistatin levels and other serum biochemical indicators. The area under the curve (AUC) for LC, viral liver cirrhosis (VLC) and alcoholic liver cirrhosis (ALC) was 0.845, 0.757 and 0.931, respectively. In conclusion, our findings demonstrated that kallistatin, a plasma protein produced by the liver, can be a useful and reliable diagnostic indicator of hepatic health status, especially for LC.
RESUMEN
Aim To investigate the changes of content of L-carnitine (LC ), acetyl-L-carnitine (ALC ) and propionyl-L-carnitine (PLC )in patients with diabetes and its complications.Methods By replicating meth-od of pre-column derivatization HPLC,the contents of plasma LC,ALC,PLC were detercted in normal sub-jects and in patients of diabetes mellitus,diabetic reti-nopathy, diabetic nephropathy, diabetic peripheral neuropathy,diabetic hypertension,diabetic coronary heart disease.Results The concentration of LC in normal subjects and in patients of diabetes mellitus, diabetic retinopathy, diabetic nephropathy, diabetic peripheral neuropathy,diabetic hypertension,diabetic coronary heart disease were (41.01 ±8.05 )μmol · L-1 ,(36.72 ±8.23 )μmol · L-1 ,(33.3 1 ±6.26 )μmol·L-1 ,(33.81 ±5.61 )μmol·L-1 ,(33.57 ± 6.67 )μmol · L-1 , (33.67 ±5.36 )μmol · L-1 , (32.87 ±6.05 )μmol · L-1 respectively.The plasma LC concentration in diabetic group was significantly lower than that of normal control group (P<0.05 ). Moreover,the LC concentration in other groups of dia-betic complications was lower than that in diabetic group, and LC concentration showed no significant difference in various groups of diabetic complications. There was no significant difference in the plasma con-centrations of ALC and PLC of diabetes group and the diabetic complication groups too.Conclusion In Chi-nese normal subjects,patients with diabetes and dia-betic complications,the plasma concentrations of LC in diabetic patients are lower than normal,and plasma concentration of LC in diabetic complications are lower than that in patients with diabetes mellitus.
RESUMEN
Objetivo. Evaluar el efecto de la oferta de kikuyo y el tercio de lactancia sobre el perfil de ácidos grasos en la grasa láctea de bovinos en pastoreo. Materiales y métodos. Se utilizaron 18 vacas de la raza Holstein con un peso promedio de 585 ±10 kg entre dos y cuatro partos, en primer y segundo tercio de lactancia. Las vacas se dividieron en tres grupos y fueron asignados al azar a uno de los tres tratamientos (ofertas de 2.6; 3.3 ó 4.0 kg MS/100 kg PV). Se determinó el perfil de ácidos grasos en la leche los días 14 y 21 del periodo experimental. Resultados. Los ácidos grasos C6:0, C16:0, C18:1c9 y C18:3 permanecieron constantes entre las diferentes ofertas de forraje y tercios de lactancia. En las mayores ofertas se presentó un aumento entre el día 14 y 21 de los ácidos C10:0 y C12:0 mientras que disminuyeron su concentración en estos mismos días los ácidos C18:1t11, C18:2c9c12, C18:2c9t11 y poliinsaturados. Se presentó una mayor concentración del ALC en animales de segundo tercio respecto a los de primero. Conclusiones. Debido a las variaciones entre los días de muestreo en el perfil de ácidos grasos de la grasa láctea fue imposible determinar si el aumento en la oferta mejora las concentraciones de ácidos grasos que han presentado efecto benéfico en la salud humana. La movilización de reservas de grasa podría explicar el comportamiento diferente de la concentración de ácidos grasos entre los días de recolección de muestras.
Objective. To evaluate the effect of kikuyu offer and stage of lactation on fatty acids profile on milk fat of grazing dairy bovines. Materials and methods. Eighteen Holstein cows with average weight of 585±10 Kg in two to four calvings on first and second lactation stages. Cows were divided in three groups and assigned randomly to one of three treatments (pasture allowances of 2.6, 3.3 or 4.0 KgDM/100 Kg LW). Milk fatty acid profiles were determined on days 14 and 21 of the experimental period. Results. Fatty acids C6:0, C16:0, C18:1cis9, C18:3 remained constant between different forage allowances and lactation stage were used. On the treatments of highest allowance, there was an increase between days 14 and 21 of C10:0 andC12:0 acids while C18:1t11,C18:2c9c12, C18:2c9,t11, and polyunsaturated fatty acids decreased their concentration. The lowest allowance had a different behavior. A higher concentration of ALC was observed in animals of second stage compared to first stage of lactation. Conclusions. It was not possible to conclude on the effects of forage allowance on the fatty acid profile of milk, due to variations between sampling dates. It is possible that mobilization of fat storage can explain the different behavior of fatty acid concentrations between sampling days.
Asunto(s)
Leche , Ácidos Grasos , Ácidos Linoleicos ConjugadosRESUMEN
Studies with human beings and animals have shown that dietary conjugated linoleic acid (CLA) promotes changes in body structure, markedly, body fat reduction. This research aimed to assess the effect of CLA (60 percent of conjugated linoleic acid methyl ester, at the proportion of 1:1 of the 9, 11: 10, 12 isomers) on changes in body weight, subcutaneous tissue thickness, body fat mass and concentration of serum lipids (triacylglycerols, total cholesterol, LDL and HDL) in overweight dogs. Dogs of different breeds weighting 16.85±7.13 assigned in a randomized assay. Two types of diets were offered for 120 days: control (-CLA) and test (+CLA, 0.3 percent). There was no difference between control and test groups considering body weight and serum levels of triacylglycerols, total cholesterol and LDL portion. There was a significant difference between the final and initial results for subcutaneous tissue thickness and body fat mass and for serum concentration of HDL in dogs supplemented with CLA. The addition of 0.3 percent of CLA in the diet of overweight dogs decreased the fat deposition on subcutaneous tissue and the development of body fat mass but increased blood levels of HDL.
Estudos em humanos e animais têm demonstrado que o uso do ácido linoléico conjugado (ALC) promove alterações na composição corporal, principalmente reduzindo a deposição de gordura. O objetivo deste trabalho foi avaliar as alterações sobre o peso corporal, tecido adiposo subcutâneo, gordura corporal e concentração sérica de lípideos (triacilglicerol, colesterol total, LDL e HDL) de cães com sobrepeso alimentados com ALC (60 por cento de ácido linoléico conjugado metil ester, na proporção de 1:1 de 9, 11: 10, 12 isômeros) na dieta. Duas dietas foram fornecidas por quatro meses, para 14 cães com sobrepeso (16,85±7,13) de diferentes raças: dietas controle (-ALC) e teste (+ALC, 0,3 por cento). O experimento seguiu delineamento inteiramente casualizado. Não houve diferença entre os grupos para peso corporal e nível sérico de triacilglicerol, colesterol total e LDL. No entanto, foram observadas diferenças significativas entre os períodos final e inicial para tecido adiposo subcutâneo, gordura corporal e nível sérico de HDL nos cães que receberam ALC. A suplementação de 0,3 por cento de ALC na dieta de cães com sobrepeso diminuiu a deposição de lipídios no tecido subcutâneo e a gordura corporal total, mas aumentou os níveis sanguíneos de HDL.
RESUMEN
High density lipoproteins (HDL) have been inversely related with the risk of cardiovascular diseases and are considered antiatherogenic factors. The vascular protective effect of HDL is associated to the reverse cholesterol transport, where the sterol is mobilized from peripheral tissues to the liver by HDL and redistributed to circulation or delivered through the bile as free cholesterol or transformed into bile acids. In the last years it has been demonstrated that conjugated linoleic acid (CLA), an omega-6 fatty acid from ruminants, which is a mixture of positional and geometric isomers of linoleic acid, has hipolipidemic and antiatherogenic properties in animal models. However, the precise effect of CLA on HDL metabolism and the mechanisms involved in these actions have yet not been elucidated. The present work reviews the scientific literature about the possible role of CLA as an antiatherogenic factor by controlling the reverse cholesterol transport.
Las lipoproteínas de alta densidad (HDL) han sido correlacionadas inversamente con el riesgo de enfermedad cardiovascular ya que se considera que constituyen un factor de protección antiateroesclerótico. El efecto protector vascular de las HDL se asocia con la vía de transporte reverso de colesterol, proceso por el cual el esterol es movilizado desde los tejidos periféricos hacia el hígado a través de las HDL plasmáticas para ser redistribuido a la circulación, o para su remoción hacia la bilis como colesterol propiamente tal o transformado en sales biliares. Por otro lado, en los últimos a±os el ácido linoleico conjugado (ALC), un acido graso derivado de la serie omega-6 proveniente de animales rumiantes y cuya mezcla está mayoritariamente formada por los isómeros geométricos y posicionales del ácido linoleico (cis 9 trans 11 y trans 10 cis 12), ha demostrado tener propiedades hipolipemiantes y antiaterogénicas en varios modelos animales. Sin embargo, su efecto preciso sobre el metabolismo de HDL y los posibles mecanismos de acción involucrados aún no ha sido dilucidado. El presente trabajo realiza una revisión de la literatura científica en relación al rol antiaterosclerótico que puede tener el consumo de ALC a través del control del trasporte reverso del colesterol.
Asunto(s)
Humanos , Animales , Ácidos Linoleicos Conjugados/metabolismo , Enfermedades Cardiovasculares/prevención & control , Lipoproteínas HDL/metabolismo , Aterosclerosis/prevención & control , Transporte Biológico , Colesterol/metabolismoRESUMEN
Se midieron las cantidades de acido linoleico conjugado (ALC) - isómeros: cis-9, trans-11, trans-10, cis-12 y cis-10, cis-12 -en leche de estanque de la empresa NESTLE y de alimentos lácteos en Chile, mediante cromatografía de gas. El ALC encontrado fue más alto (p < 0.05) en las muestras tomadas en la ciudad de Osorno comparado con la leche de la ciudad de Los Angeles. A nivel estacional el valor más alto de ALC de leche líquida fue encontrado durante la primavera en la ciudad Osorno (1,72 g/100g), mientras que el valor más bajo se presentó en invierno (0,415 g/100g) en la ciudad de Los Angeles. La cantidad promedio de ALC en leche en polvo y de leche condensada fue de 1,967 y 1,493 g/100g respectivamente durante el año 2004. La mantequilla, el queso y la crema presentaron promedios de 1,502,0,883 y 1,900 g/ lOOg respectivamente de ALC. Se concluye que los productos lácteos analizados tienen altos valores de ALC en Chile.
The amounts of conjugated linoleic acid (ALC) - homers: cis-9, trans-11, trans-10, cis-12 and cis-10, cis-12- were measured in a milk tank of the NESTLE Company and of diary food in Chile and were analyzed through gas chromatography. The ALC was found higher (p <0.05) in samples taken in the city of Osorno compared to milk of the city of Los Angeles. The highest value was found during spring in Osorno (1,72 g/100 g), while the lowest value (0,415 g/100 g) was found in winter in Los Angeles. The average amount of ALC in milk powder and condensed milk was of 1,967 and 1,493 g/100 g, respectively, during 2004. Butter, cheese and cream had respectively an average of 1,502, 0,883 and 1,900 g/100 g. In conclusion, the diary products analyzed have a high value of ALC in Chile.
Asunto(s)
Ácidos Linoleicos Conjugados/análisis , Cromatografía de Gases , Productos Lácteos/análisis , Chile , Leche/químicaRESUMEN
Objective To explore the underlying relationship between hyperglycemic factors in type 2 diabe- tes.Methods Fifty seven type 2 diabetes with obesity (DM-OB)and 64 without obesity(DM-NOB)were recruited. Age,body mass index(BMI),hemoglobin A1c (HbA1c),homeostasis model assessment-2 insulin resistance (HO- MA-IR),high-sensitivity C-reactive protein (hsCRP),fasting plasma glucose,postprandial plasma glucose (PPG), postprandial glucose excursion(PPGE),lipid profile,blood pressure were determined.Results DM-OB subjects had significantly higher HOMA-IR,BMI,DBP,TC,hsCRP,HbAlc,LDL-C when compared with DM-NOB sub- jects.Pearson correlation analysis,in DM-OB subjects,BMI,FBG,FPG,HOMA-IR,hs-CRP were all the posi- tive relative factors(P all